Solid Tumors
A Phase 1a/1b, Open-label, Dose-escalation, and Dose-expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of IMGS-001 in Patients with Relapsed or Refractory Advanced Solid Tumors
- Details
ClinicalTrials.gov ID:
NCT06014502
Diagnosis Type:
NA
USOR Number:
- Address
,
P: